Litcius/Paper detail

Evaluation of <i>BRCA1</i> and <i>BRCA2</i> as Indicators of Response to Immune Checkpoint Inhibitors

Zhijun Zhou, Min Li

2021JAMA Network Open61 citationsDOIOpen Access PDF

Abstract

This cohort study examines the association of BRCA1 and BRCA2 with tumor mutation burden and response to immune checkpoint inhibitors.

Topics & Concepts

Computer scienceCancer Immunotherapy and BiomarkersDNA Repair MechanismsCancer Genomics and Diagnostics
Evaluation of <i>BRCA1</i> and <i>BRCA2</i> as Indicators of Response to Immune Checkpoint Inhibitors | Litcius